Azacitidine, Cedazuridine, Azacitidine, Vidaza 25 mg/ml powder for suspension for injection, Azacitidine, Cedazuridine
ASTX030-01
Phase 3 small_molecule active
Quick answer
Azacitidine, Cedazuridine, Azacitidine, Vidaza 25 mg/ml powder for suspension for injection, Azacitidine, Cedazuridine for Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) is a Phase 3 program (small_molecule) at Taiho Pharma Netherlands B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Taiho Pharma Netherlands B.V.
- Indication
- Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active